Shibuya, Kendall C.;Goel, Vikas K.;Xiong, Wei;Sham, Jonathan G.;Pollack, Seth M.;Leahy, Allison M.;Whiting, Samuel H.;Yeh, Matthew M.;Yee, Cassian;Riddell, Stanley R.;Pillarisetty, Venu G.
Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
PLoS ONE
2014
9
5
e96565

Pollack, Seth M;Jones, Robin L;Farrar, Erik A;Lai, Ivy P;Lee, Sylvia M;Cao, Jianhong;Pillarisetty, Venu G;Hoch, Benjamin L;Gullett, Ashley;Bleakley, Marie;Conrad, Ernest U;Eary, Janet F;Shibuya, Kendall C;Warren, Edus H;Carstens, Jason N;Heimfeld, Shelly;Riddell, Stanley R;Yee, Cassian
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells
Journal for ImmunoTherapy of Cancer
2014
2
1

Paszkiewicz, Paulina J.;Fräßle, Simon P.;Srivastava, Shivani;Sommermeyer, Daniel;Hudecek, Michael;Drexler, Ingo;Sadelain, Michel;Liu, Lingfeng;Jensen, Michael C.;Riddell, Stanley R.;Busch, Dirk H.
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Journal of Clinical Investigation
2016
126
11
4262-4272

Berger, C.;Sommermeyer, D.;Hudecek, M.;Berger, M.;Balakrishnan, A.;Paszkiewicz, P. J.;Kosasih, P. L.;Rader, C.;Riddell, S. R.
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
Cancer Immunology Research
2014
3
2
206-216

Turtle, Cameron J.;Hanafi, Laïla-Aïcha;Berger, Carolina;Gooley, Theodore A.;Cherian, Sindhu;Hudecek, Michael;Sommermeyer, Daniel;Melville, Katherine;Pender, Barbara;Budiarto, Tanya M.;Robinson, Emily;Steevens, Natalia N.;Chaney, Colette;Soma, Lorinda;Chen, Xueyan;Yeung, Cecilia;Wood, Brent;Li, Daniel;Cao, Jianhong;Heimfeld, Shelly;Jensen, Michael C.;Riddell, Stanley R.;Maloney, David G.
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Journal of Clinical Investigation
2016
126
6
2123-2138

Hudecek, M.;Sommermeyer, D.;Kosasih, P. L.;Silva-Benedict, A.;Liu, L.;Rader, C.;Jensen, M. C.;Riddell, S. R.
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Cancer Immunology Research
2014
3
2
125-135

Buchholz, V. R.;Flossdorf, M.;Hensel, I.;Kretschmer, L.;Weissbrich, B.;Graf, P.;Verschoor, A.;Schiemann, M.;Hofer, T.;Busch, D. H.
Disparate Individual Fates Compose Robust CD8+ T Cell Immunity
Science
2013
340
6132
630-635

Nauerth, M.;Weissbrich, B.;Knall, R.;Franz, T.;Dossinger, G.;Bet, J.;Paszkiewicz, P. J.;Pfeifer, L.;Bunse, M.;Uckert, W.;Holtappels, R.;Gillert-Marien, D.;Neuenhahn, M.;Krackhardt, A.;Reddehase, M. J.;Riddell, S. R.;Busch, D. H.
TCR-Ligand koff Rate Correlates with the Protective Capacity of Antigen-Specific CD8+ T Cells for Adoptive Transfer
Science Translational Medicine
2013
5
192
192ra87-192ra87

Jensen, Michael C.;Riddell, Stanley R.
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
Immunological Reviews
2013
257
1
127-144

Riddell, Stanley R.;Sommermeyer, Daniel;Berger, Carolina;Liu, Lingfeng (Steven);Balakrishnan, Ashwini;Salter, Alex;Hudecek, Michael;Maloney, David G.;Turtle, Cameron J.
Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition
The Cancer Journal
2014
20
2
141-144